NHLBI Funding & Resource Opportunities

national heart, lung and blood institute logo image

Office of Translational Alliances and Coordination

Funding to Enhance Biomedical Workforce Diversity

The National Heart Lung and Blood Institute (NHLBI) reminds all Program Directors/Principal Investigators (PD(s)/PI(s)) of SBIR/STTR awards that funds are available for administrative supplements to recruit and support high school, undergraduate, post-baccalaureate/post-master’s degree holders, and post-doctoral candidates that increase diversity in the research workforce.

PA-16-288 Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) 

PA-16-289 Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp) 

These administrative supplements are designed to provide support for research experiences for individuals from the identified groups throughout the continuum from high school to the faculty level. In all cases, the proposed research experience must be an integral part of the approved, ongoing research of the parent award, and it must have the potential to contribute significantly to the research career development of the candidate. Supplement requests are considered on a rolling basis and must be submitted at least 3 months prior to the start date of the diversity candidate. So, if you are considering taking on a summer intern to start in May, you must submit your request no later than January 31.

More information about the NHLBI guidelines for the supplements may be viewed HERE

Please contact Jennifer Shieh (jennifer.shieh@nih.gov) if you are interested in applying for this supplemental funding and contributing to a more diverse research workforce.

If you decide not to participate, let us know why and help design something that works by responding to the Request for Information (NOT-OD-17-008)


Starting Nov 7 - Join USPTO for an SBIR/STTR Intellectual Property Webinar Series

USPTO Intellectual Property Webinar Series for Small Businesses
Patents, Trademarks, and Copyrights!
Register Today HERE

For small businesses participating in the SBIR/STTR programs, understanding Intellectual Property (IP) - Patents, Trade Secrets, Trademarks, and Copyrights - is necessary to protect ideas, products and product names in today's knowledge economy.

Hosted by the United States Patent and Trademark Office (USPTO), these 90-minute webinars have been designed specifically to address the most common IP issues facing small businesses funded by the SBIR/STTR programs. They will cover all aspects of Intellectual Property protection, as well as help you understand your IP Data Rights under the SBIR/STTR grant/contract. Space is limited to 200 people per webinar! Register early! 

Webinars will be offered at 1 P.M. Eastern on the following days:

Monday, November 7
Overview: U.S. Intellectual Property Rights and the SBIR-STTR Stakeholders
Henry Wixon (Chief Counsel for NIST)

Tuesday, November 8
Basics US Patent Practice for the SBIR-STTR Stakeholders
Office on Innovation Development, USPTO

Wednesday, November 9
Trademarks in the US
Scott Baldwin (Trademark, USPTO)

Thursday, November 10
Copyright (Domestic and International)
Susan Anthony (Director (Acting), Global Intellectual Property Academy, USPTO

Monday, November 14
The International Trademark Portfolio
Susan Anthony (Director (Acting), Global Intellectual Property Academy, USPTO

Tuesday, November 15
Patent Cooperation Treaty (PCT) and Hague Strategies for Filing Abroad
International Patent Legal Administration, USPTO

Wednesday, November 16
Intermediate/Advanced US Patent Practice for the SBIR/STTR Stakeholders
Oleg Asanbayev (Patent Examiner, USPTO)


Nov 9 Deadline - Human Cellular Models for Predicting Individual Responses to CFTR-Directed Therapeutics

Last Receipt Date!

SBIRRFA-HL-15-027 

This program will support the technical development and validation of novel in vitro human cell-based tools for predicting the responses of individual patients to cystic fibrosis transmembrane conductance regulator (CFTR)-directed therapies for cystic fibrosis (CF) lung disease. NHLBI anticipates that outcomes of successful STTR projects will help attract strategic partners or investors to support ultimate commercialization of a personalized medicine platform that could accelerate translation of CFTR-directed therapy in patients with CF lung disease.

View a recording of the 09/23/15 webinar HERE

Submit your request for slides through the SmallBiz Inquiry form.

Questions? Contact:

Nancy Macgarvey, MD, nancy.macgarvey@nih.gov     
Program Director, Division of Lung Diseases

Please visit our website for a full list of Targeted Funding Opportunity Announcements (FOAs)


Nov 14 Deadline - Who Represents the Best of SBIR/STTR? Nominations Open for Tibbetts Award

Nominate a candidate today! HERE

The U.S. Small Business Administration (SBA) is seeking nominations for its annual Tibbetts Award.

The Tibbetts Awards are presented to those small businesses, organizations, and individuals judged to exemplify the best in the SBIR or STTR programs. The award is named for Roland Tibbetts, acknowledged as the father of the Small Business Innovation Research (SBIR) program, and is presented to companies, supporting organizations, and individuals which have leveraged the SBIR/STTR investment, or helped others do so, in a way that has generated measurable impacts.

Nomination Information:

  • Please submit formal nominations to: SBIR/STTR Firm Nomination.
  • Nominations (in PowerPoint format) are due November 14, 2016 at 11:59 PM EDT
  • Self-Nominations are permissible

Anyone can nominate a business, supporting organization and/or individual for a Tibbetts Award – including self-nominations. A full set of nomination guidelines can be found HERE or on the Nomination Form.

All Tibbetts Award winners will be selected by the SBA based on the recommendations of a panel of judges. Award notifications will be sent to the winners via e-mail the week of December 2nd, 2016 (date subject to change).


Nov 15 - 17 Meet with NHLBI at the HHS SBIR/STTR Conference in Florida

18th Annual HHS SBIR/STTR Conference 
November 15 – 17, Orlando, Florida
Register HERE 

This conference is relevant to a diverse audience, including biomedical entrepreneurs; grants and contracts administrators; and industry partners and investors.

Top 3 Reasons to Attend:

1.  Meet one-on-one with HHS SBIR/STTR program managers

Over 100 federal staff, including representatives from the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Food and Drug Administration (FDA), Small Business Administration (SBA), Administration for Community Living (ACL), and HHS Office of the Inspector General (OIG) will be holding one-on-one meetings and giving presentations. You will have the chance to get one-on-one feedback about your technology proposal!

2.  Hear from successful HHS SBIR/STTR awardees 

Gain first-hand knowledge from experienced and successful applicants, potential funding partners and companies during interactive workshops and sessions. These sessions include a diverse group of successful awardees, including women-owned small businesses and socially and economically disadvantaged small businesses.

3.  Learn how to develop a competitive application

Many sessions focus on how to develop and submit your SBIR/STTR application. Topics include:

  • How to submit your SBIR/STTR grant proposal electronically via ASSIST
  • FDA regulatory requirements for drugs and devices
  • Important considerations to protect your intellectual property
  • Top 10 Dos and Don’ts for SBIR/STTR proposal development
  • Understanding indirect costs and financial accounting systems
  • What you need to know about human subjects and animal research
  • The differences between SBIR grants and contracts

For a full listing view, the agenda


Nov 29 - Dec 1 NHLBI at the 2016 SBIR/STTR Innovation Summit in Texas

November 29 - Dec 1, Austin, Texas
Register HERE 

The 2016 SBIR/STTR Innovation Summit, being held November 29 through December 1st, 2016, in Austin, TX, is a regional opportunity for small innovative firms, researchers, innovators, and technologist.

The event, which showcases innovators, and facilitates connections with Energy, Cyber, Medical, Materials, and Systems technology investors, is co-located with the Defense Energy Innovation Summit & Showcase, and will feature national and state based innovation leaders and stakeholders, including representatives from all 11 SBIR Agencies.

The SBIR/STTR programs annually provides $2.5 billion in non-dilutive research and development funding to thousands of American based entrepreneurs, and the Austin Innovation Summit provides an opportunity for you to identify linkages to this funding pipeline, and meet one-on-one with funding decision makers.

Additional conference highlights include:

  • One-on-One Meetings with Agency Decision Makers
  • Optional pre-conference SBIR Proposal and Accounting Workshops
  • Sessions featuring Investment Leaders, DoD Primes, and Agency Leadership
  • Regional Innovation Ecosystem Leaders, including those running Innovation Clusters, Incubators, Accelerators, University Tech Transfer. and other technology based startup organizations.

Review the complete conference agenda and register today at Defense Innovation.


Dec 13 & 16 Small Biz Hangouts: How to Access Money and How to Get Clinical Adoption

Join NHLBI for a December double-header
Tuesday December 13, 2 pm ET
Taking Care of Business: Managing SBIR/STTR Grants
Register HERE

Hear from NHLBI grants management staff experts about how to speed up getting an NIH award; when you need to get approval from NIH & when you don't; and common myths and misconceptions about the SBIR/STTR grants process. 

Andre Walker, BS
Grants Management Specialist, NHLBI

Jennifer Shieh, PhD
Small Business Coordinator, NHLBI

Friday December 16, 1 pm ET
Adopting New Technologies: A System’s Perspective
Register HERE

Panelists from MedStar Health, a $5B not-for-profit regional healthcare system, will discuss the process by which a large system evaluates new technologies and ultimately adopts them as part of their clinical arsenal, to provide innovators with some insight into the barriers and hurdles they should anticipate when creating their commercialization plans.

Neil J. Weissman, MD
President, MedStar Health Research Institute
 
Denise C. Noll, RN, CPHM, CMCN
Director, Institutional Contracting & Clinical Ops Support
MedStar Health Managed Care Operations

Ron Waksman, MD
Associate Director, Division of Cardiology
MedStar Heart Institute

Eric Padmore, MHSA
Scientific Program Analyst, NHLBI

If you haven’t participated in or watched one of our NHLBI Small Biz Hangouts yet, you may be missing out.  These webinars are designed to help you understand aspects of product and company development that you didn’t learn in school. Posted videos include:

Demystifying Small Business Review

Finding the Right Regulatory Consultant

Patent Litigation, Part 1 and Part 2

Check out the full YouTube playlist.

We are always interested in hearing what you would like to learn about or looking for presenters willing to share their knowledge, so contact us and be part of the NHLBI Small Biz Hangouts.


    Dec 16 Deadline – How Can We Get More Women and Minorities to Participate in NIH SBIR/STTR Programs?

    The NIH is seeking public input on a proposed new supplement to facilitate participation of women and socially and economically disadvantaged individuals in small businesses through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs.  One of the goals of the SBIR/STTR programs is to foster and encourage participation by socially and economically disadvantaged and women-owned small businesses.  Despite SBIR/STTR awardees being eligible to apply for a diversity supplement under the existing supplement program (see above), there are very low rates of participation.  The NIH has issued a Request for Information NOT-OD-17-008 to better understand the barriers that prevent SBIR/STTR awardees from participating in the existing diversity supplement program and to inform its consideration to develop a new diversity supplement program specific to the SBIR/STTR mechanisms.

    Notice number: NOT-OD-17-008

    Responses:

    If you would like to learn more about the RFI, check the supplement notice (NOT-OD-17-008) or send your inquiries to John Sheridan (john.sheridan@nih.gov).

    Due by December 16, 2016, 11:59:59 PM EST


    New Free Regulatory Research Tool

    IRAI Digital Repository

    Wondering how to prepare for the regulatory pathway your product will follow in the US?

    There is a resource that provides free access to public domain information about FDA and its regulated technologies, IRAI.  For hints on how to use tools like this website effectively, watch our NHLBI Small Biz Hangout “Developing a Target Product Profile”.

    The objective of IRAI Digital Repository is to provide an improved platform and search engine for anyone doing serious research on FDA–regulated products. The IRAI repository initiated under a contract with the Food and Drug Administration has the objective of implementing a new system for cataloging FDA materials in an easily accessible and searchable format for research and training at academic universities and for all other stakeholders for research and training in FDA’s policies and procedures. IRAI is a full-fledged information system, not just a website, with a well-organized table of contents that is browsable like a textbook. IRAI will provide access to primary information resources and training materials of the Food and Drug Administration and other agencies that concurrently regulate aspects of the same products (e.g. USDA, FTC, CPSC, etc.).


    Market Analyses For HHS SBIR/STTR Phase I Awardees - Niche Assessment Program

    APPLY today through

    NIH SBIR/STTR Setup Form

    The Niche Assessment Program provides market insight and data that can be used to help small businesses strategically position their technology in the marketplace. The results of this program can help small businesses develop their commercialization plans for their Phase II application, and be exposed to potential partners. 

    Technology Niche Analyses® (TNA®) are provided by Foresight, for one hundred and fifty (150), HHS SBIR/STTR Phase I awardees. These analyses assess potential applications for a technology and then for one viable application, it provides an assessment of the:

    1. Needs and concerns of end-users
    2. Competing technologies and competing products
    3. Competitive advantage of the SBIR/STTR-developed technology
    4. Market size and potential market share (may include national and/or global markets)
    5. Barriers to market entry (may include but is not limited to pricing, competition,government regulations, manufacturing challenges, capital requirements, etc.)
    6. Market drivers
    7. Status of market and industry trends
    8. Potential customers, licensees, investors, or other commercialization partners
    9. The price customers are likely to pay

    Each participant receives an in-depth report of Foresight's findings. Oftentimes the small businesses can use this information in their commercialization plans which are part of their Phase II applications.

    All active HHS (NIH, CDC, FDA) SBIR/STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract) are eligible to apply. Registration is on a first come, first serve basis!

    For more information, please visitNiche Assessment Program  

    Notice: NOT-OD-16-144


    Meet NHLBI Small Business Experts

    11/1NHLBI Innovation Conference – New York City, NY

    11/1 - 11/3 -  SSTi 2016 Annual Conference – Columbus, OH

    11/2 - 11/3Life Sciences Summit – New York City, NY

    11/13 - 11/15 - Partnering for Cures – New York City, NY

    11/15 - 11/1718th Annual HHS SBIR/STTR Conference - Orlando, FL

    11/29 – 12/1National SBIR/STTR Innovation Summit – Austin, TX